Trials / Active Not Recruiting
Active Not RecruitingNCT06366802
Cohort Construction and Prognostic Model Construction for Multiple Myeloma
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- The First Affiliated Hospital of Soochow University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Multiple myeloma (MM) is a disease caused by malignant plasma cell proliferation disorder. Survival outcomes continue to vary widely even within uniformly treated clinical trial populations. How to construct a clinical prognosis model of MM through real-world data to guide the selection of treatment options, standardize patient management, and improve survival expectations, is a major problem that needs to be solved urgently. It is necessary to build an MM-specific cohort in China to comprehensively understand the characteristics of MM patients, explore treatment options, and improve prognostic factors for survival outcomes.
Conditions
Timeline
- Start date
- 2022-05-03
- Primary completion
- 2027-05-02
- Completion
- 2027-05-02
- First posted
- 2024-04-16
- Last updated
- 2024-04-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06366802. Inclusion in this directory is not an endorsement.